The U.S. Court of Appeals for the Fourth Circuit affirmed a preliminary injunction in a decision on August 13 barring Meritain Health, Inc., ProAct, Inc., Rx Valet, LLC, Advanced Pharmacy, LLC, Aqua Enterprise Inc., and Gregory Santulli from importing, advertising, or facilitating the importation of foreign-market Gilead Sciences, Inc. medications into the United States. Judge Agee wrote the opinion on appeal from the U.S. District Court for the District of Maryland, joined by Judge Harris and Senior Judge Keenan. The post In Win for Gilead, Fourth Circuit Affirms Injunction Blocking Drug Importation Scheme appeared first on IPWatchdog.com | Patents & Intellectual Property Law .